サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
表紙：ホルモン補充療法市場：療法別、投与経路別、適応症別、国別、地域別- 産業分析、市場規模、市場シェア、2023-2030年予測
市場調査レポート
商品コード
1351414

ホルモン補充療法市場：療法別、投与経路別、適応症別、国別、地域別- 産業分析、市場規模、市場シェア、2023-2030年予測

Hormone Replacement Therapy Market, By Therapy, By Route of Administration, By Indication, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2023-2030
出版日: | 発行: AnalystView Market Insights | ページ情報: 英文 299 Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.14円
ホルモン補充療法市場：療法別、投与経路別、適応症別、国別、地域別- 産業分析、市場規模、市場シェア、2023-2030年予測
出版日: 2023年09月01日
発行: AnalystView Market Insights
ページ情報: 英文 299 Pages
納期: 2～3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

レポートハイライト

ホルモン補充療法市場規模は2022年に209億8,032万米ドルと評価され、2023年から2030年にかけてCAGR 6.2％で拡大。

HRTには、経口錠剤、パッチ、局所クリーム、注射剤など、さまざまな投与オプションがあります。とはいえ、HRTを受ける決定には、潜在的なリスクとベネフィットを徹底的に評価する必要があります。医療従事者と包括的な話し合いを行い、十分な情報を得た上で、その人に合った治療法を選択することが重要です。

ホルモン補充療法市場- 市場力学：

  • 更年期症状を緩和し、女性のQOLを高めたいという願望が市場の需要を促進
  • ほてり、気分の落ち込み、骨の健康への懸念など、更年期に関連する不快症状の影響は、日常生活に大きな支障をきたします。ホルモン補充療法（HRT）は、ホルモンレベルを回復させ、症状を軽減し、関連する不快感を和らげることにより、これらの課題に対処するための価値あるソリューションとして浮上しています。このため、多くの女性が、人生の過渡期に快適さと全体的な幸福を取り戻す手段として、HRTを検討するようになっています。女性の健康増進がますます重視されるようになり、HRTの潜在的な利点に対する認識が高まっていることも、この療法の持続的な普及に寄与しています。

ホルモン補充療法市場-セグメンテーション分析：

  • ホルモン補充療法の世界市場は、治療法、投与経路、適応症、地域によって細分化されます。
  • 市場は、エストロゲンホルモン補充療法、成長ホルモン補充療法、甲状腺ホルモン補充療法、テストステロン補充療法など、さまざまな療法カテゴリーで構成されています。これらのカテゴリーの中では、エストロゲンホルモン補充療法が市場をリードしています。エストロゲンホルモン補充療法（HRT）の人気が根強いのは、ほてり、膣の乾燥、骨の健康への懸念といった更年期症状への対処に有効だからです。女性は、更年期の移行期における生活の質全般を高めるためにエストロゲンHRTを利用することが増えており、これが好ましい治療オプションとしてエストロゲンHRTが持続的に注目される要因となっています。

ホルモン補充療法市場-競合情勢：

ホルモン補充療法（HRT）の競合情勢は、現在、Novartis、Pfizer、Eli Lillyといった大手製薬企業の優位が際立っています。これらの業界大手は、その広範な調査能力と確立されたブランド認知度を活用して、幅広いホルモン製品を提供し、幅広い市場での存在感を享受しています。

さらに、TherapeuticsMD社やMithra Pharmaceuticals社など、特定の医療ニーズに対応するニッチ製剤の開発に注力する小規模な専門企業も市場に含まれています。HRT市場における競合要因は、治療効果、安全性への配慮、投与方法、患者の嗜好などです。個別化されたヘルスケアソリューションに対する需要が高まることを見越して、革新的で忍容性が高く、ユーザーフレンドリーなHRTオプションの開拓を優先する企業が、この新興国市場で競争優位に立つ可能性が高いです。

目次

第1章 ホルモン補充療法市場概要

  • 調査範囲
  • 市場推定年数

第2章 エグゼクティブサマリー

  • 市場内訳
  • 競合考察

第3章 ホルモン補充療法の主要な市場動向

  • 市場促進要因
  • 市場抑制要因
  • 市場機会
  • 今後の市場動向

第4章 ホルモン補充療法業界の調査

  • PEST分析
  • ポーターのファイブフォース分析
  • 成長見通しのマッピング
  • 規制枠組みの分析

第5章 ホルモン補充療法市場：COVID-19症の影響分析

  • 新型コロナウイルス感染症以前の影響分析
  • 新型コロナウイルス感染症後の影響分析

第6章 ホルモン補充療法の市場情勢

  • ホルモン補充療法市場シェア分析、2022年
  • 主要メーカー別の内訳データ
    • 既存企業の分析
    • 新興企業の分析

第7章 ホルモン補充療法市場- 治療法別

  • 概要
    • セグメントシェア分析（治療法別）
    • エストロゲンホルモンの補充
    • 成長ホルモンの補充
    • 甲状腺ホルモンの補充
    • テストステロンの補充

第8章 ホルモン補充療法市場- 投与経路別

  • 概要
    • 投与経路別セグメントシェア分析
    • オーラル
    • 非経口
    • 他の投与経路

第9章 ホルモン補充療法市場- 適応症別

  • 概要
    • 適応症別セグメントシェア分析
    • 閉経
    • 甲状腺機能低下症
    • 成長ホルモン欠乏症
    • その他の適応症

第10章 ホルモン補充療法市場-地域別

  • イントロダクション
  • 北米
    • 概要
    • 北米の主要メーカー
    • 米国
    • カナダ
  • 欧州
    • 概要
    • 欧州の主要メーカー
    • ドイツ
    • イタリア
    • 英国
    • フランス
    • ロシア
    • オランダ
    • スウェーデン
    • ポーランド
    • その他
  • アジア太平洋（APAC）
    • 概要
    • アジア太平洋地域の主要メーカー
    • インド
    • 中国
    • 日本
    • 韓国
    • オーストラリア
    • タイ
    • インドネシア
    • フィリピン
    • その他
  • ラテンアメリカ
    • 概要
    • ラテンアメリカの主要メーカー
    • ブラジル
    • メキシコ
    • アルゼンチン
    • コロンビア
    • その他
  • 中東とアフリカ
    • 概要
    • 中東およびアフリカの主要メーカー
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • トルコ
    • アルジェリア
    • エジプト
    • その他

第11章 主要ベンダー分析- ホルモン補充療法業界

  • 競合ダッシュボード
  • 企業プロファイル
    • Novartis Pharmaceuticals
    • Pfizer Inc.
    • Eli Lilly and Company
    • Bayer AG
    • AbbVie Inc.
    • Merck &Co., Inc.
    • Amgen Inc.
    • TherapeuticsMD, Inc.
    • Allergan plc
    • Mylan NV
    • Teva Pharmaceutical Industries Ltd.
    • Glenmark Pharmaceuticals
    • Mithra Pharmaceuticals
    • Noven Pharmaceuticals
    • Besins Healthcare

第12章 アナリストの全方位展望

図表

List of Tables

  • TABLE List of data sources
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE Hormone Replacement Therapy Market: Therapy Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Therapy
  • TABLE Global Hormone Replacement Therapy Market, by Therapy 2018-2030 (USD Million)
  • TABLE Hormone Replacement Therapy Market: Route of Administration Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Route of Administration
  • TABLE Global Hormone Replacement Therapy Market, by Route of Administration 2018-2030 (USD Million)
  • TABLE Hormone Replacement Therapy Market: Indication Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Indication
  • TABLE Global Hormone Replacement Therapy Market, by Indication 2018-2030 (USD Million)
  • TABLE Hormone Replacement Therapy Market: Regional snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global Hormone Replacement Therapy Market, by Region 2018-2030 (USD Million)
  • TABLE North America Hormone Replacement Therapy Market, by Country, 2018-2030 (USD Million)
  • TABLE North America Hormone Replacement Therapy Market, by Therapy, 2018-2030 (USD Million)
  • TABLE North America Hormone Replacement Therapy Market, by Route of Administration, 2018-2030 (USD Million)
  • TABLE North America Hormone Replacement Therapy Market, by Indication, 2018-2030 (USD Million)
  • TABLE Europe Hormone Replacement Therapy Market, by Country, 2018-2030 (USD Million)
  • TABLE Europe Hormone Replacement Therapy Market, by Therapy, 2018-2030 (USD Million)
  • TABLE Europe Hormone Replacement Therapy Market, by Route of Administration, 2018-2030 (USD Million)
  • TABLE Europe Hormone Replacement Therapy Market, by Indication, 2018-2030 (USD Million)
  • TABLE Asia Pacific Hormone Replacement Therapy Market, by Country, 2018-2030 (USD Million)
  • TABLE Asia Pacific Hormone Replacement Therapy Market, by Therapy, 2018-2030 (USD Million)
  • TABLE Asia Pacific Hormone Replacement Therapy Market, by Route of Administration, 2018-2030 (USD Million)
  • TABLE Asia Pacific Hormone Replacement Therapy Market, by Indication, 2018-2030 (USD Million)
  • TABLE Latin America Hormone Replacement Therapy Market, by Country, 2018-2030 (USD Million)
  • TABLE Latin America Hormone Replacement Therapy Market, by Therapy, 2018-2030 (USD Million)
  • TABLE Latin America Hormone Replacement Therapy Market, by Route of Administration, 2018-2030 (USD Million)
  • TABLE Latin America Hormone Replacement Therapy Market, by Indication, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Hormone Replacement Therapy Market, by Country, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Hormone Replacement Therapy Market, by Therapy, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Hormone Replacement Therapy Market, by Route of Administration, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Hormone Replacement Therapy Market, by Indication, 2018-2030 (USD Million)

List of Figures

  • FIGURE Hormone Replacement Therapy Market Segmentation
  • FIGURE Market research methodology
  • FIGURE Value chain analysis
  • FIGURE Porter's Five Forces Analysis
  • FIGURE Market Attractiveness Analysis
  • FIGURE COVID-19 Impact Analysis
  • FIGURE Pre & Post COVID-19 Impact Comparision Study
  • FIGURE Competitive Landscape; Key company market share analysis, 2022
  • FIGURE Therapy segment market share analysis, 2022 & 2030
  • FIGURE Therapy segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Route of Administration segment market share analysis, 2022 & 2030
  • FIGURE Route of Administration segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Indication segment market share analysis, 2022 & 2030
  • FIGURE Indication segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Regional segment market share analysis, 2022 & 2030
  • FIGURE Regional segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE North America Hormone Replacement Therapy Market share and leading players, 2022
  • FIGURE Europe Hormone Replacement Therapy Market share and leading players, 2022
  • FIGURE Asia Pacific Hormone Replacement Therapy Market share and leading players, 2022
  • FIGURE Latin America Hormone Replacement Therapy Market share and leading players, 2022
  • FIGURE Middle East and Africa Hormone Replacement Therapy Market share and leading players, 2022
  • FIGURE North America market share analysis by country, 2022
  • FIGURE U.S. Hormone Replacement Therapy Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Canada Hormone Replacement Therapy Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Europe Hormone Replacement Therapy Market share analysis by country, 2022
  • FIGURE Germany Hormone Replacement Therapy Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Spain Hormone Replacement Therapy Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Italy Hormone Replacement Therapy Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE France Hormone Replacement Therapy Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE UK Hormone Replacement Therapy Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Russia Hormone Replacement Therapy Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Netherlands Hormone Replacement Therapy Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Sweden Hormone Replacement Therapy Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Poland Hormone Replacement Therapy Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of the Europe Hormone Replacement Therapy Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Asia Pacific Hormone Replacement Therapy Market share analysis by country, 2022
  • FIGURE India Hormone Replacement Therapy Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE China Hormone Replacement Therapy Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Japan Hormone Replacement Therapy Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE South Korea Hormone Replacement Therapy Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Australia Hormone Replacement Therapy Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Thailand Hormone Replacement Therapy Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Indonesia Hormone Replacement Therapy Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Phillipines Hormone Replacement Therapy Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of APAC Hormone Replacement Therapy Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Latin America Hormone Replacement Therapy Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Latin America Hormone Replacement Therapy Market share analysis by country, 2022
  • FIGURE Brazil Hormone Replacement Therapy Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Mexico Hormone Replacement Therapy Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Argentina Hormone Replacement Therapy Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Colombia Hormone Replacement Therapy Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of LATAM Hormone Replacement Therapy Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Middle East and Africa Hormone Replacement Therapy Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Middle East and Africa Hormone Replacement Therapy Market share analysis by country, 2022
  • FIGURE Saudi Arabia Hormone Replacement Therapy Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE United Arab Emirates Hormone Replacement Therapy Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Israel Hormone Replacement Therapy Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Turkey Hormone Replacement Therapy Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Algeria Hormone Replacement Therapy Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Egypt Hormone Replacement Therapy Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of MEA Hormone Replacement Therapy Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
目次
Product Code: ANV1662

REPORT HIGHLIGHT

Hormone Replacement Therapy Market size was valued at USD 20,980.32 Million in 2022, expanding at a CAGR of 6.2% from 2023 to 2030.

Hormone Replacement Therapy (HRT) is a medical intervention aimed at restoring hormonal equilibrium in individuals experiencing hormonal deficiencies or imbalances. This therapy can involve the use of synthetic or naturally occurring hormones, such as estrogen, progesterone, or a combination of both. It is commonly employed to alleviate symptoms associated with menopause or specific medical conditions. The primary objective of HRT is to mitigate discomforting symptoms like hot flashes, mood swings, and the loss of bone density.

HRT offers a range of administration options, including oral tablets, patches, topical creams, and injectable formulations. Nonetheless, the decision to undergo HRT necessitates a thorough evaluation of potential risks and benefits. It is essential for individuals to engage in comprehensive discussions with healthcare professionals to make well-informed and personalized choices regarding their treatment journey.

Hormone Replacement Therapy Market - Market Dynamics:

  • Desire to alleviate menopausal symptoms and enhance quality of life for women to propel market demand
  • The impact of menopause-related discomforts, which can encompass issues like hot flashes, mood swings, and bone health concerns, can significantly disrupt daily life. Hormone Replacement Therapy (HRT) emerges as a valuable solution for addressing these challenges by restoring hormone levels, reducing symptoms, and easing associated discomfort. This prompts many women to consider HRT as a means of regaining comfort and overall well-being during this transitional phase of life. The increasing emphasis on women's health empowerment, coupled with a growing awareness of the potential benefits of HRT, contributes to the sustained popularity of this therapy.

Hormone Replacement Therapy Market - Key Insights:

  • The Global Hormone Replacement Therapy Market is categorized based on Therapy, Route of Administration, and Region.
  • This market is divided into various categories depending on Therapy, including Estrogen Hormone Replacement, Growth Hormone Replacement, Thyroid Hormone Replacement, and Testosterone Hormone Replacement. Among these, Estrogen Hormone Replacement held the largest market share in 2022.
  • In terms of Route of Administration, the market is segmented into Oral, Parenteral, and Transdermal. Parenteral was the leading route of administration in 2022.
  • When it comes to regions, Asia Pacific emerged as the leading revenue generator in 2022.

Hormone Replacement Therapy Market- Segmentation Analysis:

  • The Global Hormone Replacement Therapy Market is segmented based on Therapy, Route of Administration, Indication, and Region.
  • The market consists of various Therapy categories, including Estrogen Hormone Replacement, Growth Hormone Replacement, Thyroid Hormone Replacement, and Testosterone Replacement. Among these categories, Estrogen Hormone Replacement takes the lead in dominating the market. The popularity of Estrogen Hormone Replacement Therapy (HRT) persists due to its effectiveness in addressing menopausal symptoms like hot flashes, vaginal dryness, and bone health concerns. Women increasingly turn to Estrogen HRT to enhance their overall quality of life during the menopausal transition, contributing to its sustained prominence as a preferred therapeutic option.

Hormone Replacement Therapy Market- Competitive Landscape:

The competitive landscape of Hormone Replacement Therapy (HRT) is currently marked by the dominance of major pharmaceutical giants like Novartis, Pfizer, and Eli Lilly. These industry leaders leverage their extensive research capabilities and well-established brand recognition to offer a range of hormone products while enjoying a wide market presence.

Moreover, the market includes smaller, specialized companies such as TherapeuticsMD and Mithra Pharmaceuticals, which focus on developing niche formulations to cater to specific healthcare needs. Competition within the HRT market is influenced by factors like treatment effectiveness, safety considerations, administration methods, and patient preferences. In anticipation of the growing demand for personalized healthcare solutions, companies that prioritize the development of innovative, well-tolerated, and user-friendly HRT options are likely to gain a competitive edge in this evolving market.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL HORMONE REPLACEMENT THERAPY MARKET KEY PLAYERS

  • Novartis Pharmaceuticals
  • Pfizer Inc.
  • Eli Lilly and Company
  • Bayer AG
  • AbbVie Inc.
  • Merck & Co., Inc.
  • Amgen Inc.
  • TherapeuticsMD, Inc.
  • Allergan plc
  • Mylan N.V.
  • Teva Pharmaceutical Industries Ltd.
  • Glenmark Pharmaceuticals
  • Mithra Pharmaceuticals
  • Noven Pharmaceuticals
  • Besins Healthcare

GLOBAL HORMONE REPLACEMENT THERAPY MARKET, BY THERAPY

  • Estrogen Hormone Replacement
  • Growth Hormone Replacement
  • Thyroid Hormone Replacement
  • Testosterone Replacement

GLOBAL HORMONE REPLACEMENT THERAPY MARKET, BY ROUTE OF ADMINISTRATION

  • Oral
  • Parenteral
  • Other Routes of Administration

GLOBAL HORMONE REPLACEMENT THERAPY MARKET, BY INDICATION

  • Menopause
  • Hypothyroidism
  • Growth Hormone Deficiency
  • Other Indications

GLOBAL HORMONE REPLACEMENT THERAPY MARKET, BY REGION

  • North America
    • The U.S.
    • Canada
  • Europe
    • Germany
    • France
    • Italy
    • Spain
    • United Kingdom
    • Russia
    • Netherlands
    • Sweden
    • Poland
    • Rest of Europe
  • Asia Pacific
    • India
    • China
    • South Korea
    • Japan
    • Australia
    • Thailand
    • Indonesia
    • Philippines
    • Rest of APAC
  • Latin America
    • Brazil
    • Mexico
    • Argentina
    • Colombia
    • Rest of LATAM
  • The Middle East and Africa
    • Saudi Arabia
    • United Arab Emirates
    • Israel
    • Turkey
    • Algeria
    • Egypt
    • Rest of MEA

Table of Contents

1. Hormone Replacement Therapy Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Hormone Replacement Therapy Market Snippet by Therapy
    • 2.1.2. Hormone Replacement Therapy Market Snippet by Route of Administration
    • 2.1.3. Hormone Replacement Therapy Market Snippet by Indication
    • 2.1.4. Hormone Replacement Therapy Market Snippet by Country
    • 2.1.5. Hormone Replacement Therapy Market Snippet by Region
  • 2.2. Competitive Insights

3. Hormone Replacement Therapy Key Market Trends

  • 3.1. Hormone Replacement Therapy Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Hormone Replacement Therapy Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Hormone Replacement Therapy Market Opportunities
  • 3.4. Hormone Replacement Therapy Market Future Trends

4. Hormone Replacement Therapy Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Hormone Replacement Therapy Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Hormone Replacement Therapy Market Landscape

  • 6.1. Hormone Replacement Therapy Market Share Analysis, 2022
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Hormone Replacement Therapy Market - By Therapy

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Therapy, 2022 & 2030 (%)
    • 7.1.2. Estrogen Hormone Replacement
    • 7.1.3. Growth Hormone Replacement
    • 7.1.4. Thyroid Hormone Replacement
    • 7.1.5. Testosterone Replacement

8. Hormone Replacement Therapy Market - By Route of Administration

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Route of Administration, 2022 & 2030 (%)
    • 8.1.2. Oral
    • 8.1.3. Parenteral
    • 8.1.4. Other Routes of Administration

9. Hormone Replacement Therapy Market - By Indication

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Indication, 2022 & 2030 (%)
    • 9.1.2. Menopause
    • 9.1.3. Hypothyroidism
    • 9.1.4. Growth Hormone Deficiency
    • 9.1.5. Other Indications

10. Hormone Replacement Therapy Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2022 & 2030 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. Hormone Replacement Therapy Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.2.7.3. U.S. Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
      • 10.2.7.4. U.S. Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.2.7.5. U.S. Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.2.8.3. Canada Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
      • 10.2.8.4. Canada Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.2.8.5. Canada Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. Hormone Replacement Therapy Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.7.3. Germany Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
      • 10.3.7.4. Germany Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.3.7.5. Germany Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
    • 10.3.8. Italy
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.8.3. Italy Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
      • 10.3.8.4. Italy Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.3.8.5. Italy Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
    • 10.3.9. United Kingdom
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.9.3. United Kingdom Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
      • 10.3.9.4. United Kingdom Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.3.9.5. United Kingdom Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
    • 10.3.10. France
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.10.3. France Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
      • 10.3.10.4. France Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.3.10.5. France Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
    • 10.3.11. Russia
      • 10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.11.2. Russia Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
      • 10.3.11.3. Russia Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.3.11.4. Russia Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
    • 10.3.12. Netherlands
      • 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.12.2. Netherlands Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
      • 10.3.12.3. Netherlands Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.3.12.4. Netherlands Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
    • 10.3.13. Sweden
      • 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.13.2. Sweden Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
      • 10.3.13.3. Sweden Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.3.13.4. Sweden Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
    • 10.3.14. Poland
      • 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.14.2. Poland Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
      • 10.3.14.3. Poland Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.3.14.4. Poland Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
    • 10.3.15. Rest of Europe
      • 10.3.15.1. Overview
      • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.15.3. Rest of the Europe Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
      • 10.3.15.4. Rest of the Europe Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.3.15.5. Rest of the Europe Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. Hormone Replacement Therapy Key Manufacturers in Asia Pacific
    • 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.4.4. Asia Pacific Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
    • 10.4.5. Asia Pacific Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 10.4.6. Asia Pacific Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
    • 10.4.7. India
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.7.3. India Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
      • 10.4.7.4. India Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.4.7.5. India Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
    • 10.4.8. China
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.8.3. China Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
      • 10.4.8.4. China Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.4.8.5. China Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
    • 10.4.9. Japan
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.9.3. Japan Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
      • 10.4.9.4. Japan Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.4.9.5. Japan Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
    • 10.4.10. South Korea
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.10.3. South Korea Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
      • 10.4.10.4. South Korea Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.4.10.5. South Korea Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.11.3. Australia Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
      • 10.4.11.4. Australia Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.4.11.5. Australia Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
    • 10.4.12. Thailand
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.12.3. Thailand Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
      • 10.4.12.4. Thailand Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.4.12.5. Thailand Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
    • 10.4.13. Indonesia
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.13.3. Indonesia Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
      • 10.4.13.4. Indonesia Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.4.13.5. Indonesia Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.14.3. Philippines Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
      • 10.4.14.4. Philippines Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.4.14.5. Philippines Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
    • 10.4.15. Rest of APAC
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.15.3. Rest of APAC Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
      • 10.4.15.4. Rest of APAC Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.4.15.5. Rest of APAC Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
  • 10.5. Latin America
    • 10.5.1. Overview
    • 10.5.2. Hormone Replacement Therapy Key Manufacturers in Latin America
    • 10.5.3. Latin America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.5.4. Latin America Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
    • 10.5.5. Latin America Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 10.5.6. Latin America Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.7.3. Brazil Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
      • 10.5.7.4. Brazil Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.5.7.5. Brazil Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.8.3. Mexico Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
      • 10.5.8.4. Mexico Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.5.8.5. Mexico Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.9.3. Argentina Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
      • 10.5.9.4. Argentina Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.5.9.5. Argentina Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.10.3. Colombia Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
      • 10.5.10.4. Colombia Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.5.10.5. Colombia Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
  • 10.6. Middle East and Africa
    • 10.6.1. Overview
    • 10.6.2. Hormone Replacement Therapy Key Manufacturers in Middle East and Africa
    • 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.6.4. Middle East and Africa Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
    • 10.6.5. Middle East and Africa Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 10.6.6. Middle East and Africa Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
    • 10.6.8. United Arab Emirates
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.8.3. United Arab Emirates Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
      • 10.6.8.4. United Arab Emirates Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.6.8.5. United Arab Emirates Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.9.3. Israel Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
      • 10.6.9.4. Israel Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.6.9.5. Israel Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.10.3. Turkey Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
      • 10.6.10.4. Turkey Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.6.10.5. Turkey Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.11.3. Algeria Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
      • 10.6.11.4. Algeria Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.6.11.5. Algeria Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.12.3. Egypt Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
      • 10.6.12.4. Egypt Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.6.12.5. Egypt Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
    • 10.6.13. Rest of MEA
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.13.3. Rest of MEA Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
      • 10.6.13.4. Rest of MEA Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.6.13.5. Rest of MEA Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)

11. Key Vendor Analysis- Hormone Replacement Therapy Industry

  • 11.1. Competitive Dashboard
  • 11.2. Company Profiles
    • 11.2.1. Novartis Pharmaceuticals
    • 11.2.2. Pfizer Inc.
    • 11.2.3. Eli Lilly and Company
    • 11.2.4. Bayer AG
    • 11.2.5. AbbVie Inc.
    • 11.2.6. Merck & Co., Inc.
    • 11.2.7. Amgen Inc.
    • 11.2.8. TherapeuticsMD, Inc.
    • 11.2.9. Allergan plc
    • 11.2.10. Mylan N.V.
    • 11.2.11. Teva Pharmaceutical Industries Ltd.
    • 11.2.12. Glenmark Pharmaceuticals
    • 11.2.13. Mithra Pharmaceuticals
    • 11.2.14. Noven Pharmaceuticals
    • 11.2.15. Besins Healthcare

12. 360 Degree Analyst View

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us